2 months ago
LLY
AnalystsGeoff MeachamGeoff Meacham's Stock Forecasts
AnalystsGeoff Meacham
Analyst Ranking
Bottom 7%
#4282 out of 4565 analysts
Average Return
-3.38%
Win Rate
46%49 out of 106
Risk vs Reward
Poor
Good
Geoff Meacham's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Coherent CorpCOHR | +150.48% | $26.29 | $65.85 | 2020-03-23 - 2021-03-23 | Strong Buy |
Checkmate Pharmaceuticals IncCMPI | +144.76% | $4.29 | $10.50 | 2021-10-06 - 2022-05-27 | Strong Buy |
LianbioLIANY | +92.44% | $4.22 | $0.32 | 2024-01-03 - 2024-03-18 | Sell |
Seagen IncSGEN | +85.57% | $55.30 | $102.62 | 2018-10-26 - 2019-10-25 | Strong Buy |
Bioxcel Therapeutics IncBTAI | +83.38% | $20.52 | $37.63 | 2020-04-01 - 2021-04-01 | Strong Buy |
Geoff Meacham Analyst Color
Get additional color on Geoff Meacham's coverage of popular stocks
3 months ago
LLY
9 months ago
MRNA
a year ago
LLY
a year ago
PFE
a year ago
MRK
a year ago
PFE
2 years ago
MRNA
2 years ago
PFE
Geoff Meacham's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Johnson & JohnsonJNJ | 2 | Hold | $170.00 | +15.79% | Maintains | 10 days ago |
Regeneron Pharmaceuticals IncREGN | 4 | Sell | $720.00 | -19.16% | Maintains | 15 days ago |
Royalty Pharma PLCRPRX | 2 | Strong Buy | $38.00 | +35.18% | Maintains | 15 days ago |
Biogen IncBIIB | 9 | Hold | $260.00 | +28.42% | Maintains | 15 days ago |
Bioxcel Therapeutics IncBTAI | 3 | Strong Buy | $7.00 | +168.20% | Maintains | a month ago |
Janux Therapeutics IncJANX | 2 | Strong Buy | $48.00 | +1.91% | Maintains | a month ago |
Eli Lilly & CoLLY | 8 | Strong Buy | $1,000.00 | +37.96% | Maintains | 2 months ago |
Kymera Therapeutics IncKYMR | 3 | Hold | $30.00 | -10.04% | Downgrades | 4 months ago |
LianbioLIANY | 1 | Sell | $3.00 | +840.44% | Downgrades | 4 months ago |
Bristol Myers Squibb CoBMY | 7 | Hold | $60.00 | +34.23% | Downgrades | 4 months ago |
Igm Biosciences IncIGMS | 2 | Hold | $8.00 | +4.58% | Downgrades | 4 months ago |
Amgen IncAMGN | 6 | Hold | $290.00 | +7.65% | Reinstates | 7 months ago |
Neumora Therapeutics IncNMRA | 1 | Strong Buy | $18.00 | +98.68% | Initiates Coverage On | 7 months ago |
Vir Biotechnology IncVIR | 2 | Hold | $14.00 | +83.49% | Downgrades | 8 months ago |
Gilead Sciences IncGILD | 5 | Strong Buy | $95.00 | +45.55% | Upgrades | 8 months ago |
Curevac NvCVAC | 4 | Sell | $8.00 | +246.32% | Maintains | 8 months ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $17.00 | +159.15% | Maintains | 8 months ago |
Turnstone Biologics CorpTSBX | 1 | Strong Buy | $18.00 | +520.69% | Initiates Coverage On | 8 months ago |
Moderna IncMRNA | 5 | Hold | $150.00 | +41.27% | Maintains | 9 months ago |
Biomarin Pharmaceutical IncBMRN | 1 | Strong Buy | $185.00 | +125.14% | Maintains | 9 months ago |
Acumen Pharmaceuticals IncABOS | 3 | Strong Buy | $14.00 | +338.87% | Reinstates | 9 months ago |
Intercept Pharmaceuticals IncICPT | 5 | Sell | $14.00 | -26.32% | Maintains | a year ago |
Pfizer IncPFE | 6 | Hold | $45.00 | N/A | Maintains | a year ago |
Lenz Therapeutics IncLENZ | 3 | Sell | $2.00 | N/A | Downgrades | a year ago |
Amylyx Pharmaceuticals IncAMLX | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | a year ago |
Merck & Co IncMRK | 5 | Strong Buy | $130.00 | N/A | Upgrades | a year ago |
Abbvie IncABBV | 11 | Hold | $165.00 | N/A | Maintains | a year ago |
Inovio Pharmaceuticals IncINO | 4 | Sell | $24.00 | N/A | Downgrades | a year ago |
Omeros CorpOMER | 2 | Hold | $4.00 | N/A | Downgrades | 2 years ago |
Kiniksa Pharmaceuticals LtdKNSA | 2 | Strong Buy | $34.00 | N/A | Maintains | 2 years ago |
Vaxxinity IncVAXX | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 2 years ago |
Tyra Biosciences IncTYRA | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Checkmate Pharmaceuticals IncCMPI | 1 | Strong Buy | $7.00 | N/A | Upgrades | 3 years ago |
Bridgebio Pharma IncBBIO | 2 | Strong Buy | $75.00 | N/A | Upgrades | 3 years ago |
Erasca IncERAS | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 3 years ago |
Century Therapeutics IncIPSC | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 3 years ago |
Lyell Immunopharma IncLYEL | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Y Mabs Therapeutics IncYMAB | 3 | Strong Buy | $56.00 | N/A | Upgrades | 3 years ago |
Esperion Therapeutics IncESPR | 2 | Hold | $35.00 | N/A | Downgrades | 3 years ago |
Seagen IncSGEN | 6 | Strong Buy | N/A | N/A | Upgrades | 3 years ago |
Galecto IncGLTO | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 3 years ago |
Pmv Pharmaceuticals IncPMVP | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 4 years ago |
Crispr Therapeutics AgCRSP | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 4 years ago |
Meiragtx Holdings PLCMGTX | 1 | Strong Buy | $20.00 | N/A | Reinstates | 4 years ago |
Sangamo Therapeutics IncSGMO | 1 | Strong Buy | $20.00 | N/A | Reinstates | 4 years ago |
Poseida Therapeutics IncPSTX | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Puma Biotechnology IncPBYI | 1 | Sell | $9.00 | N/A | Reinstates | 4 years ago |
Regenxbio IncRGNX | 1 | Strong Buy | $60.00 | N/A | Reinstates | 4 years ago |
Genfit SaGNFT | 1 | Sell | $7.00 | N/A | Initiates Coverage On | 4 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | $51.00 | N/A | Initiates Coverage On | 4 years ago |
Coherent CorpCOHR | 1 | Strong Buy | $31.00 | N/A | Initiates Coverage On | 4 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $110.00 | N/A | Downgrades | 4 years ago |
United Therapeutics CorpUTHR | 2 | Strong Sell | $95.00 | N/A | Maintains | 5 years ago |
Myovant Sciences LtdMYOV | 2 | Strong Buy | $25.00 | N/A | Upgrades | 5 years ago |
Dbv Technologies SaDBVT | 2 | Hold | $8.00 | N/A | Downgrades | 5 years ago |
Ptc Therapeutics IncPTCT | 7 | Hold | $40.00 | N/A | Maintains | 5 years ago |
Gritstone Bio IncGRTS | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 6 years ago |
Neurocrine Biosciences IncNBIX | 2 | Strong Buy | $135.00 | N/A | Maintains | 6 years ago |
Prothena Corp Public Ltd CoPRTA | 2 | Strong Sell | N/A | N/A | Downgrades | 6 years ago |
Zymeworks IncZYME | 2 | Hold | N/A | N/A | Upgrades | 6 years ago |
Ironwood Pharmaceuticals IncIRWD | 1 | Hold | $20.00 | N/A | Maintains | 6 years ago |
Incyte CorpINCY | 2 | Strong Buy | $135.00 | N/A | Maintains | 6 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Acceleron Pharma IncXLRN | 2 | Strong Buy | $54.00 | N/A | Maintains | 6 years ago |
Celgene CorpCELG | 4 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Vertex Pharmaceuticals IncVRTX | 2 | Strong Buy | $200.00 | N/A | Maintains | 6 years ago |
Alnylam Pharmaceuticals IncALNY | 4 | Strong Buy | $158.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.